Dermata Therapeutics DRMA SEC Filings

NASDAQ DRMA
$0.81 -0.06 (-6.71%)
As of: Oct 21, 2026 · 2:40 PM EDT
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Dermata Therapeutics, Inc. (DRMA) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
1EFFECTOthers9999999995-26-003304Oct 20, 2026 12:15 AM-
2S-3Prospectus0001493152-26-046518Oct 9, 2026 4:05 PM
34Insider Transaction0001493152-26-039048Aug 18, 2026 9:25 PM
44Insider Transaction0001493152-26-039046Aug 18, 2026 9:21 PM
58-KCurrent Report0001493152-26-038647Aug 17, 2026 8:30 AM
610-QQuarterly & Annual Report0001493152-26-037127Aug 11, 2026 4:07 PM
78-KCurrent Report0001493152-26-037124Aug 11, 2026 4:06 PM
88-KCurrent Report0001493152-26-036109Aug 5, 2026 12:30 PM
94Insider Transaction0001493152-26-028884Jun 16, 2026 8:15 PM
10S-8Prospectus0001493152-26-027275Jun 4, 2026 8:15 PM
11SCHEDULE 13DBeneficial Ownership Report0001493152-26-026642Jun 1, 2026 8:34 PM
12EFFECTOthers9999999995-26-001810May 29, 2026 4:15 AM
13424B3Prospectus0001493152-26-026446May 29, 2026 9:25 PM
148-KCurrent Report0001493152-26-025441May 27, 2026 4:57 PM-
15S-3/AOthers0001493152-26-025073May 22, 2026 5:15 PM-
1610-QQuarterly & Annual Report0001493152-26-022719May 13, 2026 4:08 PM
178-KCurrent Report0001493152-26-022710May 13, 2026 4:05 PM
18SCHEDULE 13GBeneficial Ownership Report0000921895-26-001059Apr 22, 2026 8:19 PM
19ARSOthers0001493152-26-017912Apr 17, 2026 9:05 PM
20DEFA14AOthers0001493152-26-017911Apr 17, 2026 9:03 PM
21DEF 14AOthers0001493152-26-017909Apr 17, 2026 9:01 PM
22PRE 14AOthers0001493152-26-015348Apr 7, 2026 9:49 PM
2310-KQuarterly & Annual Report0001493152-26-012992Mar 26, 2026 9:17 PM
248-KCurrent Report0001493152-26-012991Mar 26, 2026 9:16 PM
254Insider Transaction0001493152-26-010630Mar 17, 2026 9:44 PM
264Insider Transaction0001493152-26-010630Mar 17, 2026 9:44 PM
274Insider Transaction0001493152-26-010630Mar 17, 2026 9:44 PM
288-KCurrent Report0001493152-26-008037Feb 25, 2026 9:05 PM
29SCHEDULE 13DBeneficial Ownership Report0001493152-26-007792Feb 23, 2026 12:56 AM
30SCHEDULE 13DBeneficial Ownership Report0001493152-26-007792Feb 23, 2026 12:56 AM
31SCHEDULE 13DBeneficial Ownership Report0001493152-26-007792Feb 23, 2026 12:56 AM
32SCHEDULE 13GBeneficial Ownership Report0001172661-26-001308Feb 18, 2026 9:49 PM
33SCHEDULE 13GBeneficial Ownership Report0001172661-26-001308Feb 18, 2026 9:49 PM
34SCHEDULE 13GBeneficial Ownership Report0001172661-26-001308Feb 18, 2026 9:49 PM
35SCHEDULE 13GBeneficial Ownership Report0001172661-26-001248Feb 17, 2026 2:48 AM
36SCHEDULE 13GBeneficial Ownership Report0001172661-26-001248Feb 17, 2026 2:48 AM
37SCHEDULE 13GBeneficial Ownership Report0001172661-26-001248Feb 17, 2026 2:48 AM
38SCHEDULE 13GBeneficial Ownership Report0000921895-26-000261Feb 9, 2026 10:45 PM
398-KCurrent Report0001493152-26-004905Feb 3, 2026 9:05 PM
40SCHEDULE 13DBeneficial Ownership Report0001493152-26-004801Feb 2, 2026 11:35 PM
41EFFECTOthers9999999995-26-000354Jan 29, 2026 5:15 AM
42424B3Prospectus0001493152-26-004247Jan 29, 2026 10:12 PM
43CORRESPOthers0001493152-26-003812Jan 27, 2026 9:34 PM
44UPLOADOthers0000000000-26-000945Jan 27, 2026 9:09 PM
458-KCurrent Report0001493152-26-003715Jan 27, 2026 2:08 PM
46424B5Prospectus0001493152-26-003706Jan 27, 2026 1:00 PM
47S-3Prospectus0001493152-26-003259Jan 22, 2026 10:02 PM
48SCHEDULE 13DBeneficial Ownership Report0001493152-26-000967Jan 8, 2026 9:05 PM
49DOthers0001493152-26-000797Jan 7, 2026 9:05 PM
504Insider Transaction0001493152-26-000698Jan 6, 2026 1:00 AM
...

Dermata Therapeutics, Inc. SEC Filings API

Pull Dermata Therapeutics, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=DRMA&formtype=10-K,10-Q&api_key=YOUR_API_KEY